Tag: BIIB

Finance

Investor’s Watch List: Zillow Inc (NASDAQ:Z), Pacific Ethanol (NASDAQ:PEIX), Biogen Idec Inc (NASDAQ:BIIB), The Kroger Co. (NYSE:KR)

Zillow, Inc. (NASDAQ:Z), the leading real estate information marketplace, today announced it entered into an exclusive partnership with Beijing Yisheng Leju Information Services Co. (“Leju”), an affiliate of E-House (China) Holdings Limited (NYSE: EJ), a leading real estate services company in China, to power Leju’s U.S. home shopping experience. Zillow Inc (NASDAQ:Z) stock performance was 0.37% in last session and finished the day at $92.61. … Continue reading Investor’s Watch List: Zillow Inc (NASDAQ:Z), Pacific Ethanol (NASDAQ:PEIX), Biogen Idec Inc (NASDAQ:BIIB), The Kroger Co. (NYSE:KR)

Jason Knox
Finance

Trending Stocks: Biogen Idec (NASDAQ:BIIB), The Procter & Gamble (NYSE:PG), Epizyme Inc (NASDAQ:EPZM), Johnson & Johnson (NYSE:JNJ)

Biogen Idec Inc. (NASDAQ:BIIB) announced it will report first quarter 2014 financial results on Wednesday, April 23, 2014, before the financial markets open. Biogen Idec Inc (NASDAQ:BIIB) stock performance was 1.28% in last session and finished the day at $309.79. Traded volume was 1.71million shares in the last session and the average volume of the stock remained 1.63million shares. The beta of the stock remained … Continue reading Trending Stocks: Biogen Idec (NASDAQ:BIIB), The Procter & Gamble (NYSE:PG), Epizyme Inc (NASDAQ:EPZM), Johnson & Johnson (NYSE:JNJ)

Jason Knox
Finance

Biotech Losers: BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Celldex Therapeutics, Inc. (NASDAQ:CLDX), Novavax, Inc. (NASDAQ:NVAX), Biogen Idec Inc (NASDAQ:BIIB)

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) and AstraZeneca (NYSE:AZN) are among those companies with late stage drugs in trials that specifically target genetic mutations. Both BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)’s BMN-673, which is in phase 3 trials, and Astra’s Olaparib, which may get the EU’s go-ahead in ovarian cancer this year, address a mutation of the BRCA 1 and BRCA 2 gene that is often associated with breast … Continue reading Biotech Losers: BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Celldex Therapeutics, Inc. (NASDAQ:CLDX), Novavax, Inc. (NASDAQ:NVAX), Biogen Idec Inc (NASDAQ:BIIB)

Jayne Crisman
Finance

5 Stocks in Dramatic Moves: CMS Energy Corp. (NYSE:CMS), Noble Corp plc (NYSE:NE), The Sherwin-Williams (NYSE:SHW), Biogen Idec (NASDAQ:BIIB), Packaging Corporation (NYSE:PKG)

On Jan. 22, the Board of Directors of CMS Energy Corp. (NYSE:CMS) increased today the quarterly dividend on the company’s common stock by 7.4 percent, to 29 cents per share, up from 27 cents per share. CMS Energy Corp. (NYSE:CMS) belongs to Utilities sector. Its net profit margin is 6.70% and weekly performance is 1.93%. On last trading day company shares ended up $37.49. CMS … Continue reading 5 Stocks in Dramatic Moves: CMS Energy Corp. (NYSE:CMS), Noble Corp plc (NYSE:NE), The Sherwin-Williams (NYSE:SHW), Biogen Idec (NASDAQ:BIIB), Packaging Corporation (NYSE:PKG)

Jason Knox
Finance

Stocks in Focus: Biogen Idec Inc. (NASDAQ:BIIB), Care.com, Inc. (NYSE:CRCM), Chart Industries Inc. (NASDAQ:GTLS), Armada Hoffler Properties, Inc. (NYSE:AHH), Precision Castparts (NYSE:PCP)

Biogen Idec Inc. (NASDAQ:BIIB)’s CEO George A. Scangos sold 1,128 shares of the company’s stock in a transaction that occurred on Monday, November 3rd. The shares were sold at an average price of $320.78, for a total transaction of $361,839.84. Biogen Idec Inc. (NASDAQ:BIIB) belongs to Healthcare sector. Its net profit margin is 27.80% and weekly performance is -4.78%. On last trading day company shares … Continue reading Stocks in Focus: Biogen Idec Inc. (NASDAQ:BIIB), Care.com, Inc. (NYSE:CRCM), Chart Industries Inc. (NASDAQ:GTLS), Armada Hoffler Properties, Inc. (NYSE:AHH), Precision Castparts (NYSE:PCP)

Harvey Dyer